-
In the Issue: Ongoing safety review of tiotropium; raloxifene reduces the risk of endometrial cancer; one-day treatment with famciclovir may be as effective as 3-day treatment with valacyclovir; new Clinical Practice Guideline from the American College of Physicians regarding pharmacologic treatment for low bone density and osteoporosis; FDA Actions.
-
Cigarettes and pregnancy are a risky combination, and there is an abundance of data to indicate that perinatal outcome is improved if patients can abstain from smoking.
-
-
-
A new web-based data management system serving clinical research has improved data collection and accuracy through an ongoing data collection and analysis process.
-
-
Many in IRB circles have worried about the potential existence of "seeding" trials, which are defined as clinical trials that seek to market a product rather than answer a legitimate scientific question.
-
IRBs striving to ensure they're not inadvertently approving a seeding trial have a tough job ahead of them.
-
People participating in pain research report having complex combinations of reasons for enrolling part altruism, part seeking new treatments, part simply having their pain understood and taken seriously.
-
Barbara Bierer, MD, professor of medicine at Harvard Medical School, and the senior vice president for research and the director of faculty development and diversity at Brigham and Women's Hospital in Boston, MA, is the new chair of the U.S. Health and Human Services (HHS) Secretary's Advisory Committee on Human Research Protections (SACHRP).
